{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System Erythromycin (0.0625-8 \u03bcg/mL)",
        "BD Phoenix Automated Microbiology System Quinupristin/dalfopristin (0.25-4 \u03bcg/mL)",
        "BD Phoenix Automated Microbiology System Chloramphenicol (1-32 \u03bcg/mL)"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K060218",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K033784",
        "K022172",
        "K033889"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "March 17, 2006",
    "Summary Letter Received Date": "January 27, 2006",
    "Submission Date": "January 26, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Erythromycin",
        "Quinupristin/dalfopristin",
        "Chloramphenicol"
    ],
    "Specimen Type(s)": [
        "Aerobic Gram-negative bacteria isolates",
        "Aerobic Gram-positive bacteria isolates",
        "Facultative anaerobic bacteria isolates",
        "Pure culture"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth based microdilution",
        "Redox indicator",
        "Bacterial turbidity measurement",
        "Automated antimicrobial susceptibility testing"
    ],
    "Methodologies": [
        "Minimum inhibitory concentration (MIC) determination",
        "Antimicrobial susceptibility testing",
        "Organism identification"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Panel",
        "Reagent",
        "Broth",
        "Indicator solution"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System with Erythromycin, Quinupristin/dalfopristin, and Chloramphenicol for automated susceptibility testing of aerobic and facultative anaerobic bacteria from pure cultures",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of most Gram-negative aerobic and facultative anaerobic bacteria isolates for Enterobacteriaceae, Non-Enterobacteriaceae, and most Gram-positive bacteria isolates belonging to Staphylococcus, Enterococcus, and Streptococcus from pure culture",
    "fda_folder": "Microbiology"
}